CN110068645B - 液质联用检测尿液中环磷酸腺苷的方法 - Google Patents
液质联用检测尿液中环磷酸腺苷的方法 Download PDFInfo
- Publication number
- CN110068645B CN110068645B CN201910265327.4A CN201910265327A CN110068645B CN 110068645 B CN110068645 B CN 110068645B CN 201910265327 A CN201910265327 A CN 201910265327A CN 110068645 B CN110068645 B CN 110068645B
- Authority
- CN
- China
- Prior art keywords
- camp
- mobile phase
- solution
- concentration
- urine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 title claims abstract description 58
- 238000000034 method Methods 0.000 title claims abstract description 47
- 210000002700 urine Anatomy 0.000 title claims abstract description 42
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 title claims abstract description 14
- 239000012071 phase Substances 0.000 claims abstract description 64
- 150000002500 ions Chemical class 0.000 claims abstract description 29
- 238000001514 detection method Methods 0.000 claims abstract description 28
- 238000002414 normal-phase solid-phase extraction Methods 0.000 claims abstract description 17
- 238000010828 elution Methods 0.000 claims abstract description 13
- 238000005349 anion exchange Methods 0.000 claims abstract description 12
- 239000012085 test solution Substances 0.000 claims abstract description 12
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 238000012544 monitoring process Methods 0.000 claims abstract description 8
- 238000001819 mass spectrum Methods 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims abstract description 4
- 239000000523 sample Substances 0.000 claims description 37
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 27
- 239000012086 standard solution Substances 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 12
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 8
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 6
- 239000005695 Ammonium acetate Substances 0.000 claims description 6
- 235000019257 ammonium acetate Nutrition 0.000 claims description 6
- 229940043376 ammonium acetate Drugs 0.000 claims description 6
- 238000004949 mass spectrometry Methods 0.000 claims description 6
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- 238000004811 liquid chromatography Methods 0.000 claims description 4
- 239000013558 reference substance Substances 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000012417 linear regression Methods 0.000 claims description 3
- 239000007791 liquid phase Substances 0.000 claims description 3
- 239000011259 mixed solution Chemical group 0.000 claims description 3
- 235000011056 potassium acetate Nutrition 0.000 claims description 3
- 239000001632 sodium acetate Substances 0.000 claims description 3
- 235000017281 sodium acetate Nutrition 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000004445 quantitative analysis Methods 0.000 claims description 2
- 239000012088 reference solution Substances 0.000 claims description 2
- 239000012488 sample solution Substances 0.000 claims description 2
- 238000012360 testing method Methods 0.000 claims description 2
- 238000004704 ultra performance liquid chromatography Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 5
- 230000035945 sensitivity Effects 0.000 abstract description 5
- 238000004885 tandem mass spectrometry Methods 0.000 abstract description 4
- 238000000926 separation method Methods 0.000 abstract description 2
- 238000005259 measurement Methods 0.000 description 7
- 239000003463 adsorbent Substances 0.000 description 5
- 238000013537 high throughput screening Methods 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- HQVFCQRVQFYGRJ-UHFFFAOYSA-N formic acid;hydrate Chemical compound O.OC=O HQVFCQRVQFYGRJ-UHFFFAOYSA-N 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 102000003982 Parathyroid hormone Human genes 0.000 description 2
- 108090000445 Parathyroid hormone Proteins 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 238000010813 internal standard method Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 239000000199 parathyroid hormone Substances 0.000 description 2
- 229960001319 parathyroid hormone Drugs 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 102400000321 Glucagon Human genes 0.000 description 1
- 102400000050 Oxytocin Human genes 0.000 description 1
- 101800000989 Oxytocin Proteins 0.000 description 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000002552 multiple reaction monitoring Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
- 229960001723 oxytocin Drugs 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000013062 quality control Sample Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910265327.4A CN110068645B (zh) | 2019-04-03 | 2019-04-03 | 液质联用检测尿液中环磷酸腺苷的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910265327.4A CN110068645B (zh) | 2019-04-03 | 2019-04-03 | 液质联用检测尿液中环磷酸腺苷的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110068645A CN110068645A (zh) | 2019-07-30 |
CN110068645B true CN110068645B (zh) | 2021-09-03 |
Family
ID=67366929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910265327.4A Active CN110068645B (zh) | 2019-04-03 | 2019-04-03 | 液质联用检测尿液中环磷酸腺苷的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110068645B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112964818A (zh) * | 2021-02-05 | 2021-06-15 | 山东省产品质量检验研究院 | 一种检测化妆品中环磷酸腺苷的方法 |
CN116735772B (zh) * | 2023-08-16 | 2023-10-24 | 天津医科大学总医院 | 一种用于尿液分析的腺苷含量检测方法及系统 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000505046A (ja) * | 1995-08-18 | 2000-04-25 | パーデュー・リサーチ・ファウンデーション | ドーパミン受容体リガンドとしての新規の融合イソキノリン類 |
NL2010214C2 (en) * | 2013-01-31 | 2014-08-04 | Brainlabs B V | Novel diagnostic method for diagnosing depression and monitoring therapy effectiveness. |
CN104198617B (zh) * | 2014-09-18 | 2016-06-15 | 宁夏大学 | 同时测定小柴胡颗粒中环磷酸腺苷、黄芩苷和甘草酸含量的方法 |
CN108152387A (zh) * | 2017-11-22 | 2018-06-12 | 新疆农垦科学院 | 一种红枣中环磷酸腺苷的分析方法 |
-
2019
- 2019-04-03 CN CN201910265327.4A patent/CN110068645B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN110068645A (zh) | 2019-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110068645B (zh) | 液质联用检测尿液中环磷酸腺苷的方法 | |
CN113049719A (zh) | 一种检测游离睾酮的方法及试剂盒 | |
CN114720704B (zh) | 一种测定血清中游离睾酮的试剂盒及方法 | |
CN112986433A (zh) | 检测人血清样本中类固醇含量的方法 | |
CN112162043A (zh) | 生物体液中糖皮质激素的液相色谱串联质谱检测方法 | |
CN111239303B (zh) | 一种液质联用同时测定人血浆中替格瑞洛及其活性代谢物和内源性腺苷浓度的方法 | |
CN111896643A (zh) | 一种人血浆中儿茶酚胺的液相色谱串联质谱检测方法 | |
CN110794072A (zh) | 人血清中雌酮和雌二醇液相色谱串联质谱检测方法 | |
CN113009036A (zh) | 一种检测性激素的试剂盒、性激素样品前处理方法及同时检测多种性激素的方法 | |
CN113341027A (zh) | 高效液相色谱串联质谱检测唾液中睾酮的方法及试剂盒 | |
CN112394124A (zh) | 一种血浆中西地那非、n-去甲基西地那非及n1,n4-去二甲基西地那非含量分析方法 | |
CN110702829B (zh) | 一种测定血浆或血清中醛固酮含量的方法 | |
CN116183801A (zh) | 检测胰岛素和c肽的液相色谱-质谱方法、试剂盒和系统 | |
CN112903836B (zh) | 体外培育熊胆粉中异丙基-β-D-硫代吡喃半乳糖苷的测定方法 | |
CN113030343A (zh) | 一种血浆中吡咯喹啉醌的液相色谱串联质谱检测方法 | |
CN112630338A (zh) | 反相高效液相色谱串联质谱法检测蚯蚓体内七种氨基酸的检测方法 | |
CN112485340A (zh) | 一种超高效液相色谱串联质谱检测血浆中1,5-脱水山梨醇的方法 | |
CN111796035A (zh) | 一种定量分析人血浆维格列汀浓度的lc-ms/ms检测方法 | |
CN111413439A (zh) | 一种快速亲水相互作用色谱-串联质谱法测定血浆中二甲双胍的方法 | |
CN117538458B (zh) | 同时定量分析14种单糖/二糖的液相色谱串联质谱分析方法 | |
CN117554536B (zh) | 一种环境水样中15种甲状腺激素的同时分析方法 | |
CN117288869B (zh) | 一种原料药中对甲苯磺酸酯类杂质的检测方法 | |
CN114563504B (zh) | 一种测定血浆中游离醛固酮含量的方法及试剂盒 | |
CN114924011B (zh) | 高效液相色谱串联质谱法检测血浆中cmpf含量的方法 | |
CN115541778B (zh) | 一种测定人血浆中阿普斯特浓度的检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221013 Address after: Building 30, Biomedical Industrial Park, No. 218, Sangtian Street, Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone, Jiangsu Province, 215000 Patentee after: SUZHOU YAOMING ZEKANG BIOTECHNOLOGY CO.,LTD. Patentee after: SHANGHAI YOUMING AUTOMETRIC MEDICAL TECHNOLOGY Co.,Ltd. Patentee after: Shanghai Yaoming aozhe medical laboratory Co.,Ltd. Address before: No. 211, Fute North Road, pilot Free Trade Zone, Pudong New Area, Shanghai 200131 Patentee before: SHANGHAI YOUMING AUTOMETRIC MEDICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |